Human papillomavirus (HPV)-related malignancies are responsible for almost all cases of
cervical cancer in women, and over 50% of all cases of head and neck carcinoma …

Highlights•Human papillomavirus (HPV) has a primordial role in the development of cervical
cancer.•Therapies currently available for cervical cancer treatment are reviewed.•The …

Recently, the interest in using nucleic acids for therapeutic applications has been
increasing. DNA molecules can be manipulated to express a gene of interest for gene …

Lymphatic remodelling in the hypoxic tumour microenvironment (TME) is critically involved
in the metastasis of cervical squamous cell carcinoma (CSCC); however, its underlying …

Prophylactic vaccines against human papillomavirus (HPV) have proven efficacy in those
who have not been infected by the virus. However, they do not benefit patients with …

Cyprinid herpesvirus 2 (CyHV-2) infection results in huge economic losses in gibel carp
(Carassius auratus gibelio) industry. In this study, we first constructed recombinant plasmids …

Despite being largely preventable through early vaccination and screening strategies,
cervical cancer is the most common type of gynecological malignancy worldwide and …

Immunotherapy for cancer has attracted considerable attention. As one of the
immunotherapeutics, tumor vaccines exert great potential for cancer immunotherapy. The …

The ability of tumor cells to evade the immune system is one of the main challenges we
confront in the fight against cancer. Multiple strategies have been developed to counteract …

Lung cancer is regarded as the major causes of patient death around the world. Although
the novel tumor immunotherapy has made great progress in the past decades, such as …